Targeted Therapeutics for Obesity Management

Targeted therapeutics for obesity management encompass a range of strategies designed to intervene at specific molecular and cellular nodes driving excessive fat accumulation and metabolic dysfunction. Approaches include receptor-specific agonists or modulators that influence appetite regulation and energy expenditure, local delivery systems to concentrate active agents within adipose depots, and advanced nanocarriers engineered for selective uptake by adipocytes. Central mechanisms exploited by these therapies involve enhancing adipose tissue browning, promoting lipolysis, modulating inflammatory pathways and improving insulin sensitivity. Innovations in materials science have yielded photothermal and catalytic platforms that remodel adipose microenvironments, while precision small-molecule modulators of nuclear receptors achieve sustained metabolic benefits with reduced off-target effects. Collectively, these programmes aim to deliver safer, more efficacious alternatives to conventional systemic drugs and invasive procedures, with the ultimate goal of curbing the global obesity epidemic and its associated comorbidities.

Research from Nature Portfolio

Recent proteomic analyses in obesity models have uncovered a panel of serum proteins whose expression patterns shift markedly under high-fat dietary stress. Key differentially expressed proteins—such as apolipoprotein-AIV, C-reactive protein and alpha 2-HS glycoprotein—have been mapped within interaction networks that reveal convergent pathways linking lipid transport, inflammatory signalling and energy homeostasis. These foundational insights into systemic biomarkers provide a roadmap for personalised interventions, enabling stratification of individuals most likely to benefit from targeted metabolic therapies and informing the design of next-generation precision drugs.

Targeted Therapeutics for Obesity Management publication trend

The graph below shows the total number of articles in targeted therapeutics for obesity management across all publications each year (not limited to Nature Index journals).

Technical terms

White adipose tissue (WAT): energy-storing fat comprised of unilocular adipocytes.

Browning: conversion of white fat cells into thermogenically active cells expressing uncoupling proteins.

Lipolysis: enzymatic breakdown of stored triglycerides into glycerol and free fatty acids.

Photothermal therapy: use of light-absorbing agents to generate localized heat and provoke cellular changes.

PPARγ (Peroxisome proliferator-activated receptor gamma): nuclear receptor governing adipocyte differentiation and metabolic regulation.

AMPK (AMP-activated protein kinase): cellular energy sensor that regulates lipid metabolism and inflammatory responses.

References

1. Mild-photothermal and nanocatalytic therapy for obesity and associated diseases. Theranostics (2024).
2. Two‐Pronged Attack: Dual Activation of Fat Reduction Using Near‐Infrared‐Responsive Nanosandwich for Targeted Anti‐Obesity Treatment. Advanced Science (2024).
3. Selective PPARγ modulator diosmin improves insulin sensitivity and promotes browning of white fat. Journal of Biological Chemistry (2023).
4. Differentially expressed serum proteins from obese Wistar rats as a risk factor for obesity-induced diseases. Scientific Reports (2020).